Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Yao, Wantong ^a,b   Ji, Shunrong ^a,b   Qin, Yi ^a,b   Yang, Jingxuan ^c   Xu, Jin ^a,b   Zhang, Bo ^a,b   Xu, Wenyan ^a,b   Liu, Jiang ^a,b   Shi, Si ^a,b   Liu, Liang ^a,b   Liu, Chen ^a,b   Long, Jiang ^a,b   Ni, Quanxing ^a,b   Li, Min ^a,b,c   Yu, Xianjun ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

HIF1 ; Pancreatic cancer; Profilin1; SIRT3

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROFILIN; PROFILIN 1; SIRTUIN 3; UNCLASSIFIED DRUG; PROTEIN BINDING; SIRT3 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CANCER SURVIVAL; CARCINOGENICITY; CONTROLLED STUDY; CYTOSKELETON; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TUMOR DIFFERENTIATION; TUMOR VOLUME; TUMOR XENOGRAFT; AGED; ANIMAL; CARCINOGENESIS; CELL PROLIFERATION; DOWN REGULATION; FEMALE; GENETICS; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; PROTEIN ANALYSIS; SURVIVAL; TUMOR CELL LINE; WESTERN BLOTTING;

AGED; ANIMALS; BLOTTING, WESTERN; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MASS SPECTROMETRY; MICE, NUDE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROFILINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEOLYSIS; SIRTUIN 3; SURVIVAL ANALYSIS;

EID: 84908396714     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-187     Document Type: Article

References (40)

1. Shi S, Yao W, Xu J, Long J, Liu C, Yu X. Combinational therapy: new hope for pancreatic cancer?. Cancer Lett 2012, 317:127-135.
2. Liu C, Long J, Liu L, Xu J, Zhang B, Yu X, Ni Q. Pancreatic stump-closed pancreaticojejunostomy can be performed safely in normal soft pancreas cases. J Surg Res 2012, 172:e11-e7.
3. Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 2010, 11:633-643.
4. Li X, Law JW, Lee AY. Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton. Oncogene 2012, 31:595-610.
5. Chin YR, Toker A. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cellmigration. Mol Cell 2012, 38:333-344.
6. Stevenson RP, Veltman D, Machesky LM. Actin-bundling proteins in cancer progression at a glance. J Cell Sci 2012, 125:1073-1079.
7. Carlsson L, Nystrom LE, Sundkvist I, Markey F, Lindberg U. Actin Polymerizability is influenced by profilin, a low-molecular weight protein in non-muscle cells. J Mol Biol 1977, 115:465-483.
8. Mazzatti DJ, Pawelec G, Longdin R, Powell JR, Forsey RJ. SELDI-TOF-MSProteinChip array profiling of T-cell clones propagated in long-term culture identifies human profilin 1 as a potential bio-marker of immunosenescence. Proteome Sci 2007, 5:7.
9. Ackermann M, Matus A. Activity-induced targeting of profilin and stabilization of dendritic spine morphology. Nat Neurosci 2003, 6:1194-1200.
10. Witke W, Sutherland JD, Sharpe A, Arai M, Kwiatkowski DJ. Profilin 1 is essential for cell survival and cell division in early mouse development. Proc Natl Acad Sci U S A 2001, 98:3832-3836.
11. Yao W, Yu X, Fang Z, Yin P, Zhao C, Li N, Wang L, Li Z, Zha X. Profilin 1 facilitates staurosporine-triggered apoptosis by stabilizing the integrin beta1-actin complex in breast cancer cells. J Cell Mol Med 2012, 16:824-835.
12. Gronborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, Sato N, Molina H, Jensen ON, Hruban RH, Goggins MG, Maitra A, Pandey A. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006, 5:157-171.
13. Janke J, Schluter K, Jandrig B, Theile M, Kolble K, Arnold W, Grinstein E, Schwartz A, Estevéz-Schwarz L, Schlag PM, Jockusch BM, Scherneck S. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin1. J Exp Med 2000, 191:1675-1686.
14. Wu N, Zhang W, Yang Y, Liang YL, Wang LY, Jin JW, Cai XM, Zha XL. Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics 2006, 6:6095-6106.
15. Zoidakis J, Makridakis M, Zerefos PG, Bitsika V, Esteban S, Frantzi M, Stravodimos K, Anagnou NP, Roubelakis MG, Sanchez-Carbayo M, Vlahou A. Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol Cell Proteomics 2012, 11:M111.009449.
16. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112:453-465.
17. Witke W. The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol 2004, 14:46-49.
18. Bae YH, Ding Z, Das T, Wells A, Gertler F, Roy P. Profilin 1 regulates PI (3, 4) P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells. Proc Natl Acad Sci U S A 2010, 107:21547-21552.
19. Zou L, Ding Z, Roy P. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation. J Cell Physiol 2010, 223:623-629.
20. Yao W, Cai X, Liu C, Qin Y, Cheng H, Ji S, Xu W, Wu C, Chen T, Xu J, Long J, Fang Z, Qu B, Hoth M, Ni Q, Zha X, Yu X. Profilin 1 potentiates apoptosis induced by staurosporine in cancer cells. Curr Mol Med 2013, 13:417-428.
21. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52.
22. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, Pandolfi PP, Haigis MC. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 2011, 19:416-428.
23. Haigis MC, Deng CX, Finley LW, Kim HS, Gius D. SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis. Cancer Res 2012, 72:2468-2472.
24. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 2008, 8:705-713.
25. Wise DR, Ward PS, Shay JE, Cross JR, Gruber JJ, Sachdeva UM, Platt JM, DeMatteo RG, Simon MC, Thompson CB. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A 2012, 108:19611-19616.
26. Capparelli C, Whitaker-Menezes D, Guido C, Balliet R, Pestell TG, Howell A, Sneddon S, Pestell RG, Martinez-Outschoorn U, Lisanti MP, Sotgia F. CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1activation, metabolically promoting tumor growth. Cell Cycle 2012, 11:2272-2284.
27. Adekola K, Rosen ST, Shanmugam M. Glucose transporters in cancer metabolism. Curr Opin Oncol 2012, 24:650-654.
28. Ke QD, Costa M. Hypoxia-Inducible Factor-1 (HIF-1). Mol Pharmacol 2006, 70:1469-1480.
29. Cheng H, Li J, Liu C, Yao W, Xu Y, Frank TS, Cai X, Shi S, Lu Y, Qin Y, Liu L, Xu J, Long J, Ni QX, Li M, Yu XJ. Profilin1 Sensitizes Pancreatic Cancer Cells to irradiation by Inducing Apoptosis and Reducing Autophagy. Curr Mol Med 2013, 13:1368-1375.
30. Cairns RA, Harris IS, Mak TK. Regulation of cancer cell metabolism. Nat Rev Cancer 2011, 11:85-95.
31. Muñoz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: current perspectives and future directions. Cell Death Dis 2012, 3:e248.
32. Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and health span. Nat Rev Mol Cell Biol 2012, 13:225-238.
33. Finley LW, Haigis MC. Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol Med 2012, 18:516-523.
34. Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 2006, 66:8927-8930.
35. Chen Z, Lu W, Garcia-Prieto C, Huang P. The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr 2006, 39:267-274.
36. Guillaumond F, Leca J, Olivares O, Lavaut MN, Vidal N, Berthezène P, Dusetti NJ, Loncle C, Calvo E, Turrini O, Iovanna JL, Tomasini R, Vasseur S. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A 2013, 110:3919-3924.
37. Long J, Luo G, Liu C, Cui X, Satoh K, Xiao Z, Zhang B, Xu J, Ni Q, Li M, Yu X. Development of a unique mouse model for pancreatic cancer lymphatic metastasis. Int J Oncol 2012, 41:1662-1668.
38. Shi WD, Meng ZQ, Chen Z, Lin JH, Zhou ZH, Liu LM. Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis. Cancer Lett 2009, 283:84-91.
39. Huang Z, Huang S, Wang Q, Liang L, Ni S, Wang L, Sheng W, He X, Du X. MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res 2011, 71:b2582-b2589.
40. Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang Z, Wang X, Lin Y, Mao Y, Chen H, Luo J, Liu B, Zheng X, Xie L. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway. Mol Cancer 2014, 13:109.